A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting

NCT02181998 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1606

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Full dose tenecteplase
DRUG: Unfractioned heparin
DRUG: Enoxaparin

Sponsor

Boehringer Ingelheim